Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Year: 2014
Type: article
Source: Current Medicinal Chemistry
Author: A.S. Kalgutkar
Institution: Pfizer (United States)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2314930650
